Morral N, O'Neal W, Zhou H, Langston C, Beaudet A
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Hum Gene Ther. 1997 Jul 1;8(10):1275-86. doi: 10.1089/hum.1997.8.10-1275.
Experiments designed to evaluate the effect of deletion of E2a on duration of expression using adenoviral vectors led to a series of observations regarding host responses to adenoviral vectors and reporter proteins. In studies using human alpha1-antitrypsin (hAAT) as a reporter gene, we found that the duration of expression is very brief for C3H/J and CBA/J mice but is prolonged for C57BL/6J mice, that disappearance of hAAT from the blood is correlated with the appearance of antibodies, and that immunization against hAAT can prevent appearance of the protein in the blood after administration of an adenoviral vector. Deletion of E2a in hAAT vectors did not prolong expession in C3H/J or CBA/J mice and did not shorten duration of expression in C57BL/6J mice. Using similar vectors expressing Escherichia coli beta-galactosidase (beta-Gal) in immunocompetent mice, short duration of expression with a beta-Gal reporter was remarkably different from the long expression with an identical vector expressing hAAT in C57BL/6J. In the case of vectors expressing hAAT, adenoviral sequences persisted in the liver, and inflammatory responses were minimal compared to vectors expressing beta-Gal, where adenoviral sequences disappeared from the liver concomitant with a prominent inflammatory response. The duration of expression of beta-Gal in hepatocytes was increased in transgenic mice expressing the reporter in keratinocytes, indicating that host immune responses to the reporter can limit duration of expression. Dosage studies indicated that persistence of expression of hAAT can be markedly decreased by administration of high doses of vector in a manner consistent with a nonimmune-mediated toxicity following injection. These experiments indicate that host responses to reporter genes rather than host responses to adenoviral proteins can be the primary determinant of duration of expression under many experimental conditions.
旨在评估使用腺病毒载体缺失E2a对表达持续时间影响的实验,引发了一系列关于宿主对腺病毒载体和报告蛋白反应的观察结果。在使用人α1-抗胰蛋白酶(hAAT)作为报告基因的研究中,我们发现,对于C3H/J和CBA/J小鼠,hAAT的表达持续时间非常短暂,但对于C57BL/6J小鼠则会延长;hAAT从血液中消失与抗体的出现相关;并且针对hAAT的免疫接种可以在给予腺病毒载体后防止该蛋白在血液中出现。在hAAT载体中缺失E2a,并未延长C3H/J或CBA/J小鼠中的表达,也未缩短C57BL/6J小鼠中的表达持续时间。在免疫活性小鼠中使用表达大肠杆菌β-半乳糖苷酶(β-Gal)的类似载体,β-Gal报告基因的短暂表达与在C57BL/6J中表达hAAT的相同载体的长时间表达显著不同。在表达hAAT的载体中,腺病毒序列在肝脏中持续存在,与表达β-Gal的载体相比,炎症反应最小,在表达β-Gal的载体中,腺病毒序列从肝脏中消失,同时伴有明显的炎症反应。在角质形成细胞中表达报告基因的转基因小鼠中,肝细胞中β-Gal的表达持续时间增加,这表明宿主对报告基因的免疫反应可以限制表达持续时间。剂量研究表明,以与注射后非免疫介导的毒性一致的方式给予高剂量载体,可以显著降低hAAT表达的持续性。这些实验表明,在许多实验条件下,宿主对报告基因的反应而非对腺病毒蛋白的反应可能是表达持续时间的主要决定因素。